Italian Lung Cancer Observational Study
- Conditions
- Lung Cancer
- Registration Number
- NCT05851755
- Lead Sponsor
- The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
- Brief Summary
LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial disease. It involves a large proportion of reference Italian thoracic surgery centers. The relevance of the study is related to the epidemiology of lung cancer in the world - also known as "Big Killer" - and the high mortality rates both in males and females.
The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 1000
- Patients with lung cancer
- informed consent
- alcohol or drug abuse
- age < 18
- inability to express consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Lung cancer surgery outcomes 5 years Benchmarking national outcome data of the treatment of lung cancer
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of L'Aquila
🇮🇹L'Aquila, Italy